A gene therapy spinout from Children’s Hospital of Philadelphia has added a head of regulatory affairs as it continues Phase 3 clinical trials for its treatment to reverse the effects of inherited retinal degeneration caused by a mutation in the RPE65 gene. It is the latest in a series of additions to the company following […]
Contract research organizations may be critical outsourcing partners for the pharmaceutical industry but a survey of CROs indicates that turnover remains an issue. Although it has declined a bit in the U.S., turnover remains relatively high in many countries outside the U.S. It’s cause for concern because it’s an industry with a steep learning curve. […]
Transitioning to PDPM models significantly shifted the healthcare industry. By replacing the RUG system, healthcare providers cut waste and more accurately reflect the care each patient received.